Day: November 6, 2017


FDA Takes Steps to Improve Efficiency of Global Pharmaceutical Manufacturing Inspections

On Tuesday, October 31st, the FDA announced that it will begin allowing eight European drug regulatory authorities to conduct inspections of manufacturing facilities and determine whether or not they meet FDA requirements. Importance of Overseas Inspections “Some drugs approved in the U.S. are either fully manufactured overseas or made in the U.S. but contain some […] READ MORE...